Samik Basu
Chief Scientific Officer Cabaletta Bio
Seminars
Wednesday 3rd December 2025
Keynote Presentation: Showcasing Cabaletta Bio’s Rese-cel Data & Industry Implications to Progress CAR-T in Autoimmunity
9:30 am
- Explore rese-cel, a CAR-T cell therapy, combating autoimmune diseases to provide insight into the future of autoimmune cell therapies
- Discuss how translational and mechanistic insights accelerated the design and development of rese-cel in autoimmunity
- Evaluate the depth of peripheral and tissue-level target cell depletion with rese-cel in patients with autoimmune disease
Wednesday 3rd December 2025
Industry Leaders Fireside Chat: What’s Happened in the Last Year & Where is the Field Headed Next?
8:40 am
- Examining the evolution of the autoimmune cell therapy field over the last year
- Discussing progress across autologous, allogeneic, NK and in vivo modalities to uncover development strategies
- Considering indication selection strategies and the potential for indication diversification beyond lupus
- Exploring the future of the field to effectively scale and commercialise safe, durable therapies
